PHR1599
Alendronate Sodium
Pharmaceutical Secondary Standard; Certified Reference Material
Manufacturer: Supelco
CAS Number: 121268-17-5
Synonym(S): Alendronate sodium trihydrate, 4-amino-1-hydroxy-1-phosphonobutyl phosphonic acid, monosodium, MK-217
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 G | PHR1599-1-G | In Stock | ₹ 14,256.53 |
PHR1599 - 1 G
In Stock
Quantity
1
Base Price: ₹ 14,256.53
GST (18%): ₹ 2,566.175
Total Price: ₹ 16,822.705
grade
certified reference materialpharmaceutical secondary standard
Quality Level
300
Agency
traceable to BP 830traceable to Ph. Eur. Y0001727traceable to USP 1012780
API family
alendronate
CofA
current certificate can be downloaded
packaging
pkg of 1 g
technique(s)
HPLC: suitablegas chromatography (GC): suitable
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-30°C
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
MilliporeSigma™ Calbiochem™ Alendronate, Sodium Salt | -- | ₹ 23,176.49 | ||
Alendronate Sodium Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™ | -- | ₹ 15,014.30 | ||
Sigma Aldrich Fine Chemicals Biosciences Alendronate sodium trihydrate >=97% (NMR), powder | 121268-17-5 | MFCD01748233 | 100MG | -- | ₹ 28,674.02 | ||
Sigma Aldrich Fine Chemicals Biosciences Alendronate sodium United States Pharmacopeia (USP) Reference Standard | 121268-17-5 | MFCD01748233 | 200MG | -- | ₹ 47,632.80 | ||
Sigma Aldrich Fine Chemicals Biosciences Sodium alendronate trihydrate European Pharmacopoeia (EP) Reference Standard | 121268-17-5 | MFCD01748233 | | -- | ₹ 16,681.27 | ||
Alendronate sodium | -- | ₹ 40,756.13 | ||
Sodium alendronate trihydrate | -- | ₹ 14,072.50 | ||
Sodium alendronate | -- | ₹ 21,401.03 | ||
Alendronate (sodium hydrate) | -- | ₹ 445.00 - ₹ 40,495.00 | ||
121268-17-5 | sodium trihydrate hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate | -- | ₹ 445.00 - ₹ 4,094.00 |
Related Products
Description
- General description: Alendronate Sodium, an aminobisphosphonate compound, has been effectively used for the treatment of osteolysis, Paget′s disease and osteoporosis.[1]
- Application: Alendronate Sodium may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical formulations[2] and plasma samples[3] by high-performance liquid chromatography method.
- Biochem/physiol Actions: Alendronate sodium trihydrate is a bone resorption inhibitor; farnesyl diphosphate synthase inhibitor (IC50 = 460 nM); CD45 protein tyrosine phosphatase inhibitor.
- Analysis Note: These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
- Other Notes: This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
- Footnote: To see an example of a Certificate of Analysis for this material enter LRAC2083 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.
- Recommended products: Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.